Trials / Unknown
UnknownNCT03296761
Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- Jingyuan,Xu · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To observe the changes of plasma ESM-1 levels in patients with ARDS, and to explore its clinical significance.
Detailed description
70 patients who diagnosed as ARDS were included in this study. Then keep blood samples from these patients in the first day, the third day and the seventh day, detect ESM-1 level in plasma by ELISA. Record Severity of illness and survival status of every patient within 28 days. Objective to evaluate the correlation between the level of ESM-1 in plasma and the prognosis of the patients.
Conditions
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2017-12-20
- Completion
- 2018-02-20
- First posted
- 2017-09-28
- Last updated
- 2017-11-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03296761. Inclusion in this directory is not an endorsement.